Aisera vs Atomwise
Side-by-side comparison
| Aisera | Atomwise | |
|---|---|---|
| Product | Agent Composer | AtomNet |
| Category | Scientific Computing | Drug Discovery AI |
| What it does | Build, test, and deploy AI agents using natural language without coding. | Deep-learning virtual screening to find novel small-molecule hits faster |
| Pricing model | — | Partnership / Per Project |
| Free trial | — | No |
| Target company size | SMB, Mid-Market, Enterprise | Enterprise, Mid-Market |
| Deployment | SaaS | Cloud/SaaS |
| Integrations | — | Molecular Databases, Laboratory Systems |
| API available | Yes | — |
| Certifications | SOC 2 Type II, ISO 27001, CSA Star Level 1, GDPR | — |
About Agent Composer
Agent Composer is Aisera's powerful no-code/low-code platform designed for enterprises to create, test, and deploy autonomous AI agents. It empowers users to define agent behavior, capabilities, prompts, and workflows using natural language, significantly reducing the need for traditional coding expertise. This tool is a foundational component of Aisera's enterprise-grade AI agent platform, enabli
Use cases: Building autonomous AI agents using natural language, Automating complex employee requests across business services, Improving IT efficiency and support (ITSM), Integrating AI agents with existing enterprise systems and homegrown tools, Developing custom AI solutions for various departmental and domain-specific needs
About AtomNet
AtomNet is Atomwise’s (now Numerion Labs) structure-based AI platform that predicts protein–small-molecule binding to accelerate early drug discovery. It is used by pharma/biotech R&D teams and academic labs to run virtual high-throughput screening (vHTS) across extremely large, synthesizable chemical libraries and prioritize compounds for synthesis and experimental testing. The business value is
Use cases: Virtual high-throughput screening to identify initial hits for a protein target, Finding novel scaffolds for targets with limited or no known ligands (hard-to-drug targets), Prioritizing compounds for synthesis-on-demand procurement and experimental validation, Supporting partner programs from hit identification through lead optimization and candidate selection, Running multi-target discovery programs within strategic pharma collaborations